Stock Upgrades Today with Top Movers to Watch

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  16 Jul 2025
 

•   AEO  
   
  +0.31%
•   AMAT  
   
  +0.66%
•   ARM  
   
  +1.32%
•   BEP  
   
  +0.45%
•   COGT  
   
  +0.08%

$AEO American Eagle Outfitters continues to draw positive attention as UBS maintains its Buy rating. The firm’s confidence is grounded in AEO’s solid brand momentum and resilient consumer demand, suggesting potential upside in retail apparel. Investors should keep an eye on its evolving omnichannel strategy which could fuel further growth.

$AMAT Applied Materials emerges from a challenging period with an upgrade by Investor’s Business Daily. The upgrade reflects improving price performance and a stronger relative strength rating, signaling renewed investor confidence. With chip demand stabilizing and innovation in manufacturing processes accelerating, AMAT looks well-positioned for a rebound.

$ARM Arm Holdings earned an upgrade from BNP Paribas Exane based on its promising ASIC (application-specific integrated circuit) potential. As Arm’s chip designs gain traction across industries like AI and mobile computing, the company’s technology licensing model may unlock significant value, making it a compelling option for tech-focused traders.

$BEP Brookfield Renewable Partners saw its relative strength rating rise from 80 to 87, backed by consistent price appreciation. As renewable energy gains more investor favor amid sustainability trends, BEP diverse clean energy portfolio offers a steady growth avenue, especially for those seeking exposure to green infrastructure.

$COGT Jefferies reaffirmed a Buy rating and raised the price target for Cogent Biosciences. The biotech company’s promising pipeline and strategic collaborations drive optimism about its long-term growth, especially as precision oncology and targeted therapies gain momentum in the medical field.

$DIS Disney received multiple positive nods, including a price target hike from Citigroup and Barclays. As Disney expands streaming services and capitalizes on its parks recovery post-pandemic, the company diverse media empire looks poised to benefit from both content growth and evolving consumer habits.

$EQIX Guggenheim initiated coverage on Equinix with a Buy rating and a price target of $933. As a global leader in data centers, Equinix stands to benefit from increasing cloud adoption and digital infrastructure demand, positioning it well for continued capital appreciation.

$EQX Equinox Gold was upgraded by TD Securities to Buy, citing an attractive risk profile. With gold prices experiencing volatility and inflation concerns persisting, EQX offers potential safe-haven appeal and upside tied to mining operations.

$GDS GDS Holdings received an upgrade from JP Morgan from Neutral to Overweight, with an increased price target from $34 to $46. The company’s expanding footprint in China’s data center market and strong fundamentals make it a key player in cloud infrastructure growth.

$GTLB GitLab is capturing investor interest with a new Buy rating amid its big bet on AI-driven code development. As AI accelerates cloud and software innovation, GitLab’s platform for collaborative DevOps solutions is well-situated to ride this transformative wave.

$HUN Jefferies lowered Huntsman price target but kept a Buy rating, signaling cautious optimism. The chemical producer faces raw material cost pressures but benefits from strategic cost management and demand in specialty products.

$ISRG BTIG raised the price target on Intuitive Surgical while maintaining a Buy rating. As a pioneer in robotic-assisted surgery, ISRG continues to benefit from the expanding adoption of minimally invasive procedures and innovation in medical robotics.

$PLTR Mizuho upgraded Palantir to Neutral from Sell, acknowledging accelerating growth despite valuation concerns. Palantir’s expanding government and commercial contracts, particularly in data analytics and AI, underpin a cautiously optimistic outlook.

$PNC PNC Financial Services posted strong Q2 earnings with $1.6 billion net income and raised its quarterly dividend. The bank’s stable credit quality and solid loan growth underscore its resilience, making it a steady play in the financial sector.

$PYPL Seaport upgraded PayPal from Sell to Neutral, reflecting improved sentiment. Despite competitive pressures, PayPal’s diversified digital payment platform and expansion into new financial services suggest a stabilization in performance.

$RBC Deutsche Bank initiated coverage on RBC Bearings with a Buy rating. The industrial components maker stands to gain from growing aerospace and defense demand, supported by solid fundamentals and growth prospects.

$ROK Rockwell Automation was raised to Buy by Bank of America, citing improved earnings power. The company’s focus on automation and digital transformation in manufacturing provides attractive exposure to industrial innovation.

$RVMD Revolution Medicines earned a new Buy rating from Goldman Sachs. The biotech’s pipeline targeting oncology and rare diseases positions it well for future growth, supported by strategic partnerships.

$SNPS Needham raised the price target on Synopsys, maintaining a Buy rating. Synopsys’s leadership in electronic design automation aligns with growing semiconductor complexity, offering steady growth potential.

$VKTX H.C. Wainwright reiterated a Buy rating on Viking Therapeutics with a $102 price target. The biotech’s clinical pipeline and promising drug candidates drive positive sentiment among investors.

$VTR JPMorgan upgraded Ventas to Overweight with a $72 price target. The real estate investment trust benefits from stable cash flows in healthcare properties, making it attractive for income-focused investors.

$WT Goldman Sachs upgraded WisdomTree to Neutral and raised its price target. The ETF provider’s growing product lineup and asset inflows support a positive near-term outlook.

Bottom line – Among these upgrades, Applied Materials $AMAT stands out as the most attractive near-term opportunity due to its improving technical strength, strong position in a cyclical semiconductor market rebound, and robust fundamental outlook.